Astron Clinica raises £900,000 funding:
This article was originally published in Clinica
A UK company which has developed technology for imaging the microstructure of the skin has raised over £900,000 ($1.27 million) in a funding round. Toft, Cambridge-based Astron Clinica's SIAscope has been demonstrated as an aid to diagnosis of malignant melanoma, and has been applied to other skin pathologies. Chief executive John Wilkinson, who joined from Becton Dickinson in February 2001, said: "We are delighted to have raised this money in the difficult economic climate." Significant milestones for the company this year include its first sale to an NHS hospital and its first peer reviewed paper.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.